Literature DB >> 34346016

Remarkable clinical responses of non-fluctuating Parkinson's disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ~ 300 mg/day to opicapone 25 mg/day.

Kiyotaka Nakamagoe1, Hiroshi Tsuji2, Kazuhiro Ishii2, Akira Tamaoka2.   

Abstract

Entities:  

Year:  2021        PMID: 34346016     DOI: 10.1007/s10072-021-05481-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  4 in total

Review 1.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

2.  Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations.

Authors:  José-Francisco Rocha; Amílcar Falcão; Ana Santos; Roberto Pinto; Nelson Lopes; Teresa Nunes; Lyndon C Wright; Manuel Vaz-da-Silva; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2014-06-14       Impact factor: 2.953

3.  Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone.

Authors:  Petr Vokurka; Andrew Barron; Sheetal Sumaria; Lindsey Stockford; Paul Jarman; Kailash Bhatia; Simon Farmer; Tabish Saifee; Tom Warner; Rimona Weil; Sonia Gandhi; Patricia Limousin; Prasad Korlipara; Tom Foltynie
Journal:  Mov Disord Clin Pract       Date:  2020-10-21

4.  Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.

Authors:  Joaquim J Ferreira; Andrew J Lees; Werner Poewe; Olivier Rascol; José-Francisco Rocha; Birgit Keller; Patricio Soares-da-Silva
Journal:  Neurology       Date:  2018-04-25       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.